About EdgeBio
EdgeBio is a company based in Gaithersburg (United States) founded in 1989 was acquired by StoneCalibre in July 2014. EdgeBio operates in a competitive market with competitors including Rejuvenate Bio, Novogene Corporation, Clinical Microbiomics, BGI and Genewiz, among others.
- Headquarter Gaithersburg, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$109.38 K (USD), Grant
Jul 01, 2010
-
Investors
HHS
& 1 more
-
Employee Count
Not available
-
Acquired by
StoneCalibre
(Jul 08, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of EdgeBio
Investors in EdgeBio
EdgeBio has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and StoneCalibre.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
StoneCalibre is recognized as an international private investment firm.
|
Locked | Locked | Locked |
Investor details for EdgeBio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by EdgeBio
Investment portfolio details for EdgeBio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - EdgeBio
Detailed financials for EdgeBio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Edgebio Comparisons
Peer comparison for EdgeBio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of EdgeBio
EdgeBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rejuvenate Bio, Novogene Corporation, Clinical Microbiomics, BGI and Genewiz, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
|
| Locked | Locked | Locked |
Meta-genomics platforms and services for microbiome studies are provided.
|
|
| Locked | Locked | Locked |
BGI is engaged in genomics and precision medicine solutions.
|
|
| Locked | Locked | Locked |
Genomic services are provided for the life sciences industry.
|
|
| Locked | Locked | Locked |
NGS-based diagnostic solutions for neonatal screening are developed.
|
Detailed competitors of EdgeBio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Edgebio
Complete news archive for EdgeBio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EdgeBio
EdgeBio was founded in 1989 and raised its 1st funding round 21 years after it was founded.
EdgeBio is headquartered in Gaithersburg, United States. It is registered at Gaithersburg, Maryland, United States.
Manufacturer and distributor for DNA sequencing and purification. The company provides DNA sequencing and bioinformatics products and services for academic and government institutions, biopharmaceutical and biotechnology companies, and research institutions worldwide. Its services include clinical and research sequencing, consultation on experimental design, platforms, sample QC and library prep, data analysis, and bioinformatics support, biomarker sequencing, multiple target enrichment options, and automation and robotics. The companys products include sequencing clean-up, PCR purification, sample preparation, competent cells, and accessories.
EdgeBio's top competitors include Novogene Corporation, BGI and Source BioScience.
EdgeBio has 2 investors. Key investors include HHS, and StoneCalibre.